🏛️ Verified NIH Record • Updated 2026-08-26

AMAZE 12: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Maintain Their Weight Loss (NCT07503210)

Efficacy and Safety of NNC0487-0111 s.c. Once Weekly in Participants With Obesity Who Have Reached Target Dose During run-in Period (AMAZE 12)

🟢 Recruiting Phase3 💊 Investigational Drug / Biologic Sponsor: Novo Nordisk A/S

🩺 Plain-English Summary (8th-Grade Level)

The purpose of this clinical study is to find out if NNC0487-0111 is safe and effective for treating people who have excess body weight. There are 2 study treatments in this study taken as injections under the skin once a week. Participants will either get NNC0487-0111 (the treatment being tested) or Placebo (a treatment that has no active medicine in it). Which treatment participants get is decided by chance.

Who can join: Review the eligibility criteria below.

Location: Pinnacle Research Group LLC — Anniston, Alabama

Age range: 18 Years

📋 "Do I Qualify?" — 1-Minute Self Screener

Instant Checklist

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (72 Sites)

Showing the first 25 of 72 sites.

  • Pinnacle Research Group LLC — Anniston, Alabama
  • Diablo Clinical Research, Inc. — Walnut Creek, California
  • Florida Inst For Clin Res LLC — Orlando, Florida
  • Endeavor Health — Skokie, Illinois
  • Midwest Inst For Clin Res — Indianapolis, Indiana
  • Medication Mgmnt, LLC_Grnsboro — Greensboro, North Carolina
  • PMG Research of Wilmington LLC — Wilmington, North Carolina
  • UPA Ctr Weight and Eating Dis — Philadelphia, Pennsylvania
  • Clinical Res Collaborative — Cumberland, Rhode Island
  • North Texas Endocrine Center — Dallas, Texas
  • UT Southwestern Med Cntr — Dallas, Texas
  • Selma Medical Associates — Winchester, Virginia
  • Rainier Clin Res Ctr Inc — Renton, Washington
  • Conexa — Ciudad Autonoma de Buenos Aires, Buenos Aires
  • CICEMO- Consultorio (Av Directorio) — Ciudad Autónoma de Buenos Aires, Buenos Aires
  • Instituto de Investigaciones Clinicas Mar Del Plata — Mar del Plata, Buenos Aires
  • CIPREC Pueyrredon — Buenos Aires,
  • Sydney Clinical Trials — Campbelltown, New South Wales
  • Sydney Cardiometabolic Centre — Liverpool, New South Wales
  • Hunter Diabetes Centre — Merewether, New South Wales
  • Nightingale Research Adelaide — Adelaide, South Australia
  • Anima Research Center — Diepenbeek,
  • AZ Groeninge - Kortrijk - Centrum Endo - Diabetologie — Kortrijk,
  • Centre hospitalier universitaire de Liège (CHU de Liège) — Liège,
  • AZ OOSTENDE (Campus DAMIAAN) — Ostend,

📞 Contact the Study Coordinator

Phone: (866) 867-7178

Email: clinicaltrials@novonordisk.com

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

💰 Cost, Insurance & Patient Rights

  • 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
  • Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
  • Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

Explore by condition: All Obesity clinical trials

💡 How to Participate

  1. Check the checklist above to see if you may qualify.
  2. Contact the study coordinator using the phone/email above.
  3. Ask about the visit schedule, what is covered at no cost, and any travel support.
  4. Confirm with your own doctor before making a decision.
🏛️ View Official NIH Record ↗